EUCODIS Bioscience introduces new panel of Peroxidases

on .

EUCODIS is glad to announce the addition of a new enzyme family to its portfolio of recombinant industrial enzymes. Our collection of more than 20 Peroxidases is carefully selected from 10 subfamilies, and all Peroxidases display unique properties for their utility in chemical, flavor, feed, cosmetics, paper and other industries. EUCODIS Peroxidases use hydrogen peroxide as a co-substrate to catalyze reactions similar to cytochrome P450 oxidoreductases, but eliminating the need for expensive cofactor recycling systems. The enzymes are exclusively available from EUCODIS.

INVISTA and EUCODIS Bioscience collaborate on development of enzymes for production of industrial chemicals

on .

INVISTA and EUCODIS Bioscience, an Austrian biotechnology company with strong expertise in enzyme engineering and industrial enzyme development, announce a collaboration for the screening and engineering of enzymes to further develop bio-derived processes for the production of industrial chemicals.

CTAT: Further proof-of-concept data presented at PEGS Boston 2014

on .

EUCODIS presented latest developments of CTATTM,  its proprietary ADC linker technology at the10th Annual Protein Engineering Summit (PEGS) in Boston, May 5th – 9th.
CTATTM is a novel, enzyme-based technology for the directed c-terminal conjugation of antibodies with a broad spectrum of different payload molecules. In contrast to existing first generation chemical linker technologies or second generation site-specific linker technologies, the CTATTM technology combines the benefits of efficient c-terminal, site-directed conjugation without affecting the specificity and stability of the antibody.